Press Releases
Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID its Single-Dose Intranasal Vaccine Candidate for COVID-19
Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it entered into an agreement with Lonza for the manufacturing of AdCOVID™, Altimmune’s next-generation, single-dose intranasal...
Techno Trends
Facing The Chinese Challenge – Are Indian Pharmaceutical Companies Up For It?
For long India has been known to supply the world with pharmaceuticals at a very reasonable price. With that being said, immediately our focus...
News
The Falling Graph of Dose Contract Manufacturing
One could witness slow revenue growth of Dose Contract Manufacturing Organizations in 2019. Expectations were high on its revival in 2020, but unfortunately, things...
Packaging & Labelling
Biocair and Roylance Pharma partner to provide end-to-end logistics services
Biocair, a global logistics company dedicated to the life sciences, has partnered with Roylance Pharma to deliver fully integrated transportation and storage services for...
Press Releases
Lilly’s neutralizing antibody bamlanivimab receives FDA emergency use authorization for the treatment of recently diagnosed COVID-19
The U.S. FDA granted Emergency Use Authorization for Eli Lilly and Company's investigational neutralizing antibody bamlanivimab 700 mg. Bamlanivimab is authorized for the treatment...
Drug Research
Transcenta and Merck Announce a Strategic Collaboration at CIIE to Advance Continuous Biomanufacturing
Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, and Merck, a leading science and technology company,...
News
Australia begins production of Oxford Covid-19 vaccine, plans to manufacture 30 million doses
A Covid-19 vaccine co-developed by pharmaceutical company AstraZeneca and the University of Oxford is seen as one of the most promising of all the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read